<DOC>
	<DOCNO>NCT02092402</DOCNO>
	<brief_summary>The purpose study investigate effect fecal microbiota transplantation ( FMT ) symptoms irritable bowel syndrome ( IBS ) patient .</brief_summary>
	<brief_title>Fecal Microbiota Transplantation Patients With Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Inclusion criterion patient 1 . Signed informed consent 2 . Fulfilled Rome III diagnostic criterion IBS , frequency IBS pain discomfort least 2 day week last 12 week 3 . Age : 1865 year Exclusion criteria patient 1 . High proportion butyrateproducing microbiota fecal sample 2 . Known organic gastrointestinal disease ( e.g . IBD ) 3 . Previous complicate gastrointestinal surgery 4 . Nongastrointestinal malignancy 5 . Dementia , severe depression , major psychiatric disorder , incapacity adequate cooperation 6 . Females pregnant breastfeed 7 . Severe endometriosis 8 . Antimicrobial treatment 4 week prior first screen visit 9 . Antimicrobial prophylaxis ( eg . acne , urinary tract infection ) 10 . Regular consumption probiotic product 4 week prior randomization 11 . Recently ( within last 3 month ) diagnose lactose intolerance 12 . Celiac disease 13 . Abuse alcohol drug 14 . Any clinically significant disease/condition investigator 's opinion could interfere result trial Inclusion criterion donor 1 . Signed informed consent 2 . Highbutyrate produce microbiota fecal sample 3 . Age : 1865 year Exclusion criteria donor 1 . Known organic gastrointestinal disease ( e.g . IBD , IBS , chronic diarrhea constipation ) 2 . Gastrointestinal malignancy polyposis 3 . History major gastrointestinal surgery ( e.g . gastric bypass ) 4 . Eosinophilic disorder gastrointestinal tract 5 . Current communicable disease ( e.g . upper respiratory tract infection ) 6 . Known high risk infectious disease HIV , hepatitis A , B C 7 . Nongastrointestinal malignancy 8 . Dementia , severe depression , major psychiatric disorder , incapacity adequate cooperation 9 . Comorbidities metabolic syndrome , autoimmune disease , allergy 10 . Chronic pain syndrome ( eg . chronic fatigue syndrome , fibromyalgia ) 11 . Severe morbid obesity 12 . Use immunosuppressive chemotherapy agent 13 . Antimicrobial treatment prophylaxis within last 6 month 14 . Females pregnant breastfeed 15 . Known clinically significant abnormal laboratory value 16 . Participation highrisk sexual behavior 17 . Abuse alcohol drug 18 . Tattoo body pierce within last 6 month 19 . Travel area endemic diarrhea last 3 month 20 . Positive stool test C. difficile toxin , ovum , parasite , Giarda antigen , cryptosporidium antigen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Fecal transplantation</keyword>
	<keyword>microbiota transplantation</keyword>
	<keyword>irritable bowel syndrome</keyword>
	<keyword>IBS</keyword>
</DOC>